Skip to content

Comparison between Dexmedetomidine, Dexamethasone and Levobupivacaine in supraclavicular block under ultrasound guidance

A COMPARATIVE EVALUATION OF DEXAMETHASONE VERSUS DEXAMETHASONE & DEXMEDETOMIDINE AS ADJUVANTS IN COMBINATION WITH 0.25% LEVOBUPIVACAINE IN ULTRASOUND GUIDED SUPRACLAVICULAR BLOCK IN UPPER LIMB SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054593
Enrollment
60
Registered
2023-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Supraclavicular block under ultrasound guided in upper limb surgeries: A comparative evaluation of Dexamethasone versus Dexamethasone and Dexmedetomidine as adjuvant in combination with

Sponsors

Career institute of medical science and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade II/III belonging to American Society of Anaesthesiologists (ASA) Patients who have given consent Patients undergoing elective upper limb surgeries

Exclusion criteria

Exclusion criteria: Patients on adrenoreceptor agonist or antagonist therapy history of bleeding disorders history of cardiovascular disease history of respiratory disease history of renal dysfunction history of hepatic disease pregnant women, Lactating mothers the history of central Nervous system disease or neuromuscular disorders Pt on antipsychotic drugs History of hyperthyroidism Diabetic patients Coagulopathy local infection Pt allergic to Levobupivacaine , Dexamethasone and Dexmedetomidine Patients who are not willful to give consent

Design outcomes

Primary

MeasureTime frame
onset and duration of sensory blockade; onset and duration of motor blockade; duration of postoperative analgesia Timepoint: 18 months

Secondary

MeasureTime frame
intraoperative narcotic/analgesic requirement side-effects or complications Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Farhat Nesar

UP medical council

dr.priyeshlpsc@gmail.com7985975077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026